The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

Martin Pavelka; Kevin Van-Zandvoort ORCID logo; Sam Abbott ORCID logo; Katharine Sherratt; Marek Majdan; Inštitút Zdravotných Analýz; Pavol Jarčuška; Marek Krajčí; Stefan Flasche ORCID logo; Sebastian Funk ORCID logo; (2020) The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. MedRxiv. DOI: 10.1101/2020.12.02.20240648
Copy

<jats:title>Abstract</jats:title><jats:p>Slovakia conducted multiple rounds of population-wide rapid antigen testing for SARS-CoV-2 in late 2020, combined with a period of additional contact restrictions. Observed prevalence decreased by 58% (95% CI: 57-58%) within one week in the 45 counties that were subject to two rounds of mass testing, an estimate that remained robust when adjusting for multiple potential confounders. Adjusting for epidemic growth of 4.4% (1.1-6.9%) per day preceding the mass testing campaign, the estimated decrease in prevalence compared to a scenario of unmitigated growth was 70% (67-73%). Modelling suggests that this decrease cannot be explained solely by infection control measures, but requires the additional impact of isolation as well as quarantine of household members of those testing positive.</jats:p>


picture_as_pdf
2020.12.02.20240648v1.full.pdf
subject
Published Version
Available under Creative Commons: NC-ND 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads